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Background: Abdominal aortic aneurysm (AAA) is a major cause of death in developed countries. Patients often lack
clinical symptoms, most acute AAA patients do not survive rupture, and subsequent surgical repair has a signiﬁcant
postoperative mortality. Diagnostics for AAAs are currently centered on aneurysm diameter, but recent studies claim this
method to be insufﬁciently accurate. More accurate diagnostic criteria need to be indentiﬁed to minimize the amount of
unnecessary interventions and to provide earlier diagnosis of rupture-prone AAAs.
Methods: A literature study using the MEDLINE database followed by manual cross-referencing provided original studies
concerning AAA diagnostics.
Results: The currently validated imaging modalities such as ultrasound, computed tomography, and magnetic resonance
imaging allow AAA research to develop in several directions. Some studies investigate whether clinically visible entities
like thrombus, calciﬁcation, and vascular anatomy could be implemented directly into clinical practice through use of
ultrasound or computed tomography. Experimental studies on intravascular ultrasound, positron emission tomography-
computed tomography, ultrasound particle image velocimetry and superparamagnetic particles in magnetic resonance
imaging propose new methodologies to beneﬁt AAA research. Other studies focus on available technology toward
inﬂammation, metabolism, and the effects of hemodynamics on vascular integrity.
Conclusions: Contradictory outcomes, low availability of experimental imaging modalities, and an often small population
size hamper research in this ﬁeld. Introducing new techniques and biomarkers in current or experimental modalities
may prove to be the next step in the development of new diagnostic criteria for the risk assessment of AAA rupture. Until
then, the AAA diameter remains the gold standard as a clinical risk factor. (J Vasc Surg 2013;57:851-9.)Abdominal aortic aneurysm (AAA) currently is a signif-
icant cause of sudden death in developed countries. Its inci-
dence quickly follows atherosclerosis and hypertension in
cardiovascular mortality with over 15,000 AAA-related
deaths in the United States and 8000 deaths in the United
Kingdom yearly.1 Since an AAA most frequently occurs in
the former or current smoking elderly population, it is
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://dx.doi.org/10.1016/j.jvs.2012.10.097Up to now, measurement of aneurysm diameter is the
clinically approved tool for the diagnosis and follow-up of
AAAs. Small aneurysms (diameter <5.5 cm in men,
<5.0 cm in women) are followed up by routine monitoring
of growth. Should the aneurysm growmore than 1 cm/y or
over 5.5 cm (men; 5.0 cm in women), surgical intervention
is indicated. The results of these population-based studies,
however, are just partly helpful when extrapolated to the
individual level. Recent studies suggested this method of
diameter assessment only is insufﬁcient.2-4 Subjects with
aneurysm diameters well under 5.0 cm can also rupture,
whereas large aneurysms (>10 cm diameter) may also
remain intact until death from other causes. In the search
for new diagnostic methods, many different approaches
have been explored but have yet to be validated. This review
assesses current options and promising new imaging possi-
bilities in AAA rupture risk diagnostics.
METHODS
Both the UpToDate and MEDLINE/PubMed data-
bases were searched for the following terms: “abdominal
aortic aneurysm” and “AAA” as heading and “diagnosis,”851
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852 Buijs et al March 2013“computed tomography,” “CT,” “ultrasound,” “Doppler,”
“magnetic resonance,” “MR,” “imaging,” “angiography,”
“PET,” “PET-CT,” or “rupture” as keywords. Further
manual cross-referencing provided the remaining literature
needed. No limitations were set for either languages or
time periods.
Clinical risk assessment
AAA remains quiescent in most of the cases. Eventu-
ally, AAA rupture classically presents with lower back
pain, tenderness of the abdomen, and a pulsating abdom-
inal mass that is painful on palpation. A hypovolemic shock
can eventually occur. Although a less common entity,
symptomatic nonruptured AAAs present with one or
more previously stated symptoms without any form of
rupture. Often, asymptomatic patients are diagnosed inci-
dentally after receiving ultrasound (US), computed tomog-
raphy (CT), or magnetic resonance imaging (MRI) for
other indications. A few clinically available patient charac-
teristics are known as signiﬁcant risk factors. A history of
smoking and the amount of cigarettes consumed are
directly dose- and time period-dependent factors to the
development of an AAA.5 Age, male sex, and a positive
family history for AAA also increase the risk for developing
an AAA.1
Imaging modalities
Ultrasound-based techniques. US is currently the
gold standard inmonitoring growth in aneurysms. Being rela-
tively inexpensive, easy to use with low interobserver vari-
ability, and no radiation burden, US is considered the
perfect AAA screening modality.
In a retrospective cohort study, Lindholt et al6 provided
new insights in the effects of calciﬁcation on AAA develop-
ment. Through the application of US, the authors found
signiﬁcantly slower expansion rates (Wilcoxon rank-sum;
P < .001) of AAAs in men with small aneurysms
(<30 mm) containing calciﬁcation in more than 50% of
the total AAA wall circumference in comparison to men
with calciﬁcation in less than 50% of the wall circumference.
In spite of these ﬁndings, mortality was similar in both
groups (hazard ratio, 0.89; P¼ .604). AAA-related hospital
admissions were only signiﬁcantly lower in >50% calciﬁed
AAAwalls with univariate analysis and not as an independent
risk factor for hospital admission when tested in a multi-
variate model. Therefore, although calciﬁcation is not
protective against AAA symptoms and death, this study
suggests itmight be protective against aneurysm expansion.6
Some researchers speciﬁcally use the duplex and
Doppler modality of US. Whereas duplex research is mainly
focusing on discovering postsurgical endoleaks and moni-
toring AAA growth,7 Long et al8 discovered new insights
in presurgical risk assessment using Doppler imaging.
They studied 56 patients using tissue Doppler imaging
aiming to evaluate AAA behavior at different levels of
compliance and diameter. A higher maximal mean
segmental dilatation and other raised compliance markers
were found as AAA diameter increased. The authorsspeculated this to be the consequence of elastin and
collagen degradation and, thus, a marker for rupture
tendency. On the other hand, Long et al8 did not include
a control group with nonaneurysmatic abdominal aortas.
Also, the relationship with AAA outcome was left out,
therefore, they were not in the position to align their
results with ﬁrm conclusions about rupture risk.
AAA development is not just bound by morphologic
variables. Researchers have found links between hemody-
namic variables and aneurysm growth and rupture. Liu
et al9 constructed a new velocimetry technique, echo
particle image velocimetry (PIV). They combined US with
microbubbles acting as ﬂow tracers in several cardiovascular
models, including an AAA model. The authors managed to
accurately measure several different complex ﬂow patterns,
such as vorticity, stagnation, and recirculation.9 Recently,
Zhang et al10 performed a preliminary in vivo study using
this technique in ﬁve human carotid arteries. Optical PIV
is currently the gold standard for wall shear rate (WSR)
and wall shear stress (WSS) measurement. Phase-contrast
MRI also acts comparable to echo PIV in measuring WSR
and WSS. Compared with the results of optical PIV and
phase-contrast MRI, echo PIV measurements showed
highly resembling error bars. This suggests that echo PIV
is a valid method for calculating WSS and WSR. Develop-
ment of this technique could lead to clinical reproducibility
as a complement to US and may provide clinicians with
hemodynamic information or prove useful in assessing
WSS and its effects on aneurysm growth and rupture.
In the search for a more accurate diameter measure-
ment, Van Essen et al11 studied 22 AAAs with intravascular
ultrasound (IVUS) as part of preoperative assessment.
IVUS seemed not only to perform as well as CT angiog-
raphy (CTA), it also seemed “the most accurate way to
determine the morphology of vascular structures (ie,
calcium, thrombus). Previous to this research, White
et al12 already stated in their review article that IVUS is
the ultimate tool for AAA assessment. In spite of this,
IVUS remains an invasive procedure that is far less available
than US, CTA, or MRI. Its use would be an addition to the
current standard instead of an alternative, and whether the
additional costs outweigh the potential beneﬁts is still
unclear. It, therefore, is unlikely that, in its current state,
IVUS will have a great impact on AAA diagnostics.
CTA. CTA is currently the ﬁrst choice in determining
the speciﬁc AAA anatomy for preoperative assessment.13
This choice revolves solely around its ability to render
high-resolution images in acute and nonacute circum-
stances. US may perform well in screening, yet some
speciﬁc morphologic details are only presented by CTA.
Exact size, width, and length of the aneurysm are variables
that are vital in preparing AAA surgery.
Although aneurysm diameter and growth are the major
risk factors for rupture, other morphologic details are being
considered to be valuable in estimating the chances of AAA
rupture. Not only the anatomic aspects of the vessel itself
but also their association to other tissues and vertebrae
are likely to attribute to risk for AAA rupture. In a CTA-
Fig 1. Computational wall stress and rupture risk assessment in an abdominal aortic aneurysm (AAA). A three-
dimensional model is recreated from raw computed tomography (CT) data. Wall stress is measured quantitatively
and translated to a color gradient. Blue, green, and red portray low, intermediate, and high wall stress respectively.14
(Reprinted with permission from Elsevier.)
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ciation between peak AAA wall stress and risk for rupture
(Fig 1). In a later study, Fillinger et al15 failed to ﬁnd
a signiﬁcant correlation between thrombus size and AAA
rupture in a noncomputational retrospective CTA study.
Speelman et al16 opposed these results when their ﬁndings
suggested a link between intraluminal thrombi and their
inﬂuence on wall stress. Using computational interpreta-
tions of CTA scans, they discovered that an increase in
thrombus size would increase the AAA growth rate but
would also be associated with lower wall stress. Consid-
ering these ambivalent ﬁndings, the effects of intraluminal
thrombus remain controversial.
AAA is known for its rigorous change in vessel anatomy.
The aneurysmal sac grows in an unpredictable fashion
with curving and sloping against the high intravascular
pressure. These structural changes, and concomitant throm-
bosis, calciﬁcation, and atherosclerosis, affect the dynamics
of passing blood. However, these pathologic and incidental
entities are not the only cause for damaging blood ﬂow
patterns. In-born tortuosity of the vessel and otherwise
physiologically formed anatomic structures might coinci-
dentally result in damaging hemodynamics. For example,
as the abdominal aorta follows the spinal curvature, the
posterior wall is subjected to a higher hemodynamic stress
compared with the anterior wall. In the risk assessment of
AAA, a hydrodynamic engineering perspective has always
been the mainstay. The diameter criterion is based on the
law of Laplace, although it is argued that the diameter plays
only a partial role in the biomechanics of AAAs. Its inﬂu-
ence on rupture may be trivial in comparison to many other
inﬂuences on the vessel stress and strength ratio.4Therefore, the focus has shifted toward computational
AAA models for the evaluation of the different effects of
vessel anatomy. Doyle et al17 showed that asymmetric
AAAs with localized wall thickness variation portray higher
mechanical stresses and an increase in AAA rupture risk.
They also theorized how the risk of rupture is connected
to aneurysm diameter asymmetry. This might consequently
inﬂuence the amount of wall stress on the posterior
abdominal aortic wall. The asymmetry variation was calcu-
lated as the difference between the major and minor axes at
the maximum width. The authors showed that increased
asymmetry leads to increased posterior wall stress, implying
future rupture. In eight and nine out of 15 patients, diam-
eter and diameter asymmetry, respectively, were found to
be signiﬁcantly inﬂuential (P < .05) on posterior wall
stress. Doyle et al17 claimed that diameter asymmetry is
on par with current risk assessment using aneurysm
diameter.
In an earlier retrospective cohort study by Fillinger
et al,15 diameter asymmetry was calculated in CTA scans of
two different AAA risk groups, elective vs ruptured. A signif-
icantly greater diameter asymmetry (P ¼ .03; OR, 3.2) was
found with patients receiving acute aneurysm surgery.
Besides this, Fillinger et al15 found minimized tortuosity
of the aorta to be as inﬂuential a factor as smoking and
sex were on future rupture (P ¼ .01; OR, 3.3).
A number of promising software packages is being
developed for the computation analysis of available CT
and CTA images. Blood ﬂow, pressure distribution, shear
stress, and the interaction of curvature, diameter asymme-
try, and intraluminal structures on any of these factors are
part of a host of inﬂuences on the mechanics of wall
Fig 2. A male patient with impending rupture of an abdominal aortic aneurysm (AAA). Bleeding into the intraluminal
thrombus is portrayed in unenhanced (A) and contrast-enhanced (B) axial computed tomography (CT) images as
a crescentic form with hyperattenuation (arrow in A).40 (Reprinted with kind permission of D. Rakita, Department of
Radiology, Division of Body Imaging, Long Island Jewish Medical Center.)
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biomechanics-based perspective will be of great importance
for future research.
A very different entity found in CT imaging is the
ﬂowing of contrast into the thrombus combined with
transformation of the lumen. This might be the cause of
a sign called hyperattenuating crescents (Fig 2). Histopath-
ologic testing showed this phenomenon to be hemorrhage
into the thrombus and, consequently, the aneurysm wall.
Mehard et al18 and Consalves et al19 described a sign of
impending rupture characterized by high-attenuating
crescents in the AAA wall. Consalves et al19 claimed the
crescent sign to be of prognostic value for AAA rupture.
In the study by Mehard et al,18 the speciﬁcity of high-
attenuating crescents vs aneurysm complication was 93%.
Hyperattentuation was deﬁned by Siegel et al20 as a signal
being higher than contrast visibility of the psoas muscle in
enhanced scans or a signal higher than that of patent lumen
in unenhanced scans. In their study, 21% of patients with
ruptured aneurysms showed hyperattenuating crescents,
while no patients with intact aneurysms showed this sign.
Roy et al21 most recently investigated signs of bleeding in
the intraluminal thrombus and rupture site in AAA patients.
Although the crescentic form was found signiﬁcantly more
in the ruptured group rather than the stable aneurysm group
(38% vs 14%; P ¼ .02), localized areas of hyperattenuation
were found in both groups without signiﬁcant variation.
Therewas,however, a signiﬁcantlyhigher (P¼ .02) thrombus
total attenuation in the ruptured group. Roy et al21 compro-
misingly stated that “whether these ﬁndings also predict AAA
rupture, remains to be established.”
Positron emission tomography-computed tomog-
raphy (PET-CT). Up until recently, only anatomically
focused imaging modalities were used in risk assessment
of AAAs. The hybridization of PET-imaging with CT,
provides added value over the separate use of PET and CT
alone. PET enables functional imaging of cellular activity in
AAA tissue, whereas the addition of CT grants improved
anatomic localization and characterization.
The radiopharmaceutical tracer 18F-ﬂuorodeoxyglu-
cose (FDG) is designed to image high-glucose-using cells.FDG accumulates in inﬂammatory sites because of its rich
macrophage colonization. AAAs have also been proved to
attract inﬂammatory cells and cytokines like matrix metal-
loproteinases (MMPs).22 Mycotic thrombus in AAAs is
a more severe infection of the AAA, often because of
bacteremia or otherwise circulating bacteria. Mycotic aneu-
rysms tend to rupture more easily and are known for a high
mortality rate. Diagnosis of mycotic aneurysm is difﬁcult,
even on CT images. There are several suggestive signs,
such as the presence of perivascular ﬂuid or raised inﬂam-
matory blood markers, but none are either sensitive or
speciﬁc enough in most of the cases. Recently, PET-CT
has shown to be very valuable.23 PET-CT might also be
able to provide information on short-term outcomes from
pharmaceutical interventions on this infection (Fig 3).
In 2002, Sakalihasan et al24 attempted to link FDG
uptake with AAAs using PET. After performing static
whole-body PET on 26 patients, 10 showed heightened
activity in the abdominal aorta. Their preliminary research
suggested PET has the capacity to portray metabolic activity
within the aneurysm wall. In 2008, through a highly signi-
ﬁcant (r ¼ 0.93; P < .0001) association between 18F-FDG
uptake and histologically assessed macrophage-density,
Reeps et al25 were able to conﬁrm that vascular inﬂam-
mation could be detected accurately using PET-CT. In
symptomatic patients, this activity proved to be signiﬁcantly
higher than in asymptomatic patients (P < .001). During
the same year, Sakalihasan et al24 presented preliminary
results of an ongoing research. In a patient group of 26
patients, they found that subjects with positive PET scans
(n¼ 10) showed either AAA symptoms (n ¼ 5), expansion,
leakage of blood, and fulminant rupture (n¼ 3). Two PET-
positive patients remained asymptomatic. Patients with
negative PET images were treated after delay of several
months out of convenience for the patient, without experi-
encing the adverse effects as seen in the PET-positive
patients. Consequently, the authors claimed that FDG-
PET could provide an argument whether or not to justify
an intervention.26
In a longitudinal observational study, Kotze et al27 most
recently aimed to explain the relationship between FDG
Fig 3. Abdominal aortic aneurysm (AAA) images from computed tomography (CT) (A and B) and 18F-ﬂuorodeox-
yglucose (18F-FDG) positron emission tomography (PET) (C and D). The arrows show how a region with high FDG
uptake in the PET image coincides with a mural thrombus in the CT image.41 (Reprinted with permission from Elsevier.)
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imaging, the expansion was measured after 1 year and asso-
ciated with whole-vessel standardized uptake value. An
inverse correlation of –0.501 (P¼ .011) was found between
whole-vessel standardized uptake value and aneurysmal
growth. Two major study limitations were identiﬁed,
however. First, the follow-up lasted until 12 months.
Second, the follow-up was performed using US, which
has an error margin that can be larger than small AAAs
expand in a year. Nonetheless, the authors conclude their
publication implying that less metabolically active aneu-
rysms are more likely to grow and perhaps subsequently
rupture. These contradicting conclusions on the value of
FDG undermine the results presented by both authors
and might set back the research in this ﬁeld.
However, FDG is not the sole imaging agent in
PET-CT imaging of AAAs. Nahrendorf et al28 investigated
a modiﬁed dextran-coated iron oxide nanoparticle that
particularly binds to macrophages. In a murine aneurysm
model using ApoE -/- mice treated with angiotensin II,
PET-CT showed signiﬁcantly higher signals from the
AAA model (2.46 6 0.48, standard uptake value) than in
wild-type littermates (0.82 6 0.05; P < .05). Flow cytom-
etry, immunohistologic analysis, and scintillation counting
all portrayed how the nanoparticles migrated mainly to
macrophages and monocytes within the AAA wall. Several
other PET-CT reagents have been found in various
medical ﬁelds such as interleukin-2 and choline-speciﬁc
pharmaceuticals that could be applied in the ﬁeld of inﬂam-
mation PET diagnostics. It may only be a matter of time
before these are introduced to AAA diagnostics. PET-CT
is starting to prove its worth over CTA and US. Yet, the
studies performed all had a low number of patients in theircohorts, and some authors questioned the reproducibility
of their study. These results should, therefore, be regarded
as preliminary.
MRI/magnetic resonance angiogram (MRA).
Although magnetic resonance is widely accepted as an
imaging tool, its place within AAA diagnostics has not
been established. In spite of this, multiple groups have
been looking into the value of MRI and MRA in AAA
risk assessment. In 1995, Prince et al29 started assessing
the usefulness of gadolinium-enhanced MRA for the
diagnosis of AAAs. It performed equally as well as CTA,
without need of iodine-based contrast. This was a great
improvement at the time, as renal complications attrib-
utable to the high iodine concentrations in CTA contrast
were far more common.
In 2004, Kramer et al30 used gadolinium-pentetic acid
in identifying atherosclerotic ﬁbrous caps in AAAs. Using
T2-weighted MRI imaging, they managed to accurately
delineate the ﬁbrous cap and thrombus from the vessel
wall (Fig 4). Although the study was focused on identi-
fying vulnerable atherosclerotic plaques, it consequently
provided new insights on vulnerability of the AAA wall.
Also, starting from an atherosclerosis-focused perspective,
Sadat et al31 linked MRI to AAA extracellular matrix degra-
dation. Ultrasmall superparamagnetic iron oxide (USPIO)
particles are known for a strong interaction with macro-
phages and leukocytes. By observing the amount of
USPIO uptake in the cells, which translates to lower T2-
and T2* signal intensity, Sadat et al31 theorized the phago-
cytic activity in the AAA wall could be quantiﬁed. In their
study, T2- and T2* values in the AAA wall correlated
signiﬁcantly (Spearman’s correlation coefﬁcient ¼ .90;
P < .001) after injection with USPIO. This propensity to
Fig 4. A T2-weighted magnetic resonance imaging (MRI) image (A) and T1-weighted MRI image after gadolinium
pentetic acid infusion (B) of an abdominal aortic aneurysm (AAA) with intraluminal thrombus shows three distinct
layers. These components were conﬁrmed by histopathology (C). The ﬁbrous cap contained high numbers (120 white
blood cells/hpf) of polymorphonuclear leukocytes, as was seen using high power ﬁeld microscopy (D).30 (Reprinted
with permission from Elsevier.)
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is abundant. Using this technology, it seems increasingly
feasible to quantify inﬂammation and concomitantly to
quantify stability of the AAA. Regrettably, there was no
histologic control for these ﬁndings, but as a feasibility
study, it provided encouraging results for larger cohort
studies.31
Nchimi et al,32 however, did manage to provide histo-
logic backgrounds to their in vivo USPIO MRI study.
Post-USPIO signal-to-noise ratios for thrombus tissue and
muscle tissue were signiﬁcantly different (P ¼ .016), as
were the contrast-to-noise ratios for the luminal
sublayer of the thrombus (P < .001) and deeper thrombus
(P< .012).UsingUSPIO as a phagocytosis-speciﬁc imaging
agent, accurate morphologic assessment of the thrombus
can be achieved by visualizing phagocytic activity corrobo-
rating with immunohistochemical stainings. CD66b (poly-
morphonuclears), CD68 (macrophages), and pro-MMP-9
(extracellular matrix remodeling) were found in signiﬁcant
levels (P ¼ .009, P ¼ .002, P ¼ .014, respectively) opposed
to a decrease in signal intensity of the luminal sublayer of the
thrombus. USPIO is known for a high rate of liver clearance.It is, therefore, questionable whether the low signal intensity
was entirely due to high macrophage uptake or whether it
was partly due to the rapid clearance.32 Sadat et al31 also
stated that the USPIO agent used in their study is no longer
commercially available. Therefore, repetition of this research
is highly improbable. Acknowledgement through other
studies with larger cohorts, repeating, or enriching this
research is essential, as both authors state their research
was bound by the limited amount of included patients.
Bio-optical imaging. Bio-optical imaging uses tech-
niques such as chemiluminescence, bioluminescence, and
near-infrared ﬂuorescence (NIRF). As of yet, bio-optical
imaging of AAAs has only been used in experimental
settings. Luminescent probes react to a chosen substrate (eg,
MMP, VEGF) by proteolytic cleavage of the substrate and
consequently emit ﬂuorescence. Intensity of the signal is,
therefore, directly correlated to the substrate concentration
in the imaged tissue. As inﬂammation seems likely to be
involved in AAA growth and rupture, more and more indi-
vidual factors are being discovered. Inﬂammation-induced
elastin degradation in the extracellular matrix has been
shown to be of inﬂuence on AAA development. The main
Fig 5. A female patient with a symptomatic nonruptured
abdominal aortic aneurysm (AAA). Calciﬁcation was found along
the complete circumference of the vessel. The high-density signal
is distinctly visible in spite of the contrast agent in the lumen.
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their counteractor tissue inhibitor of metalloproteinase-1
(TIMP-1).33 Kaijzel et al34 proposed a new method of
AAA identiﬁcation, using MMP-speciﬁc probes in ﬁbulin-4
reduced-expression allele mice. Fibulin-4 is relevant in the
organization of extracellular matrix structures and regarded
an important factor for arterial integrity. Although mainly
affecting the ascending and descending thoracic aorta, this
speciﬁc knockdown perpetuates aortic aneurysm dilatation
in more and less severe degrees for homozygous (R/R) and
heterozygous (þ/R) knockdowns, respectively. Using
a NIRF imaging system, a dose-dependent rise in MMP
ﬂuorescence was shown in the þ/R (1.79-ns life-time) and
R/R (2.02-ns life-time) mice vs the control littermates
(<1-ns life-time). After whole mouse scanning, individual
hearts and aortas were harvested and scanned for MMP.
Control mouse aortic arch MMP signal intensity reached
19.75 relative ﬂuorescence units (rfu), whereas increased rfu
(26.53 and 105.77) were measured in þ/R and R/R mice,
respectively. Using histologic analysis, zymography, and
ﬂuorescence molecular tomography, similar results were
found. The authors suggested that NIRF imaging of MMP
could provide information on aneurysm development in the
thoracic aorta.34
Neovascularization has also been proposed to be of
value in aneurysm pathology. Nonaneurysmal aortas and
intact aneurysms demonstrate a lower degree of mural
neovascularization than ruptured aneurysms.22 Vascular
endothelial growth factor (VEGF) is a major proangiogenic
mediator. Tedesco et al35 sought to associate VEGF
receptor (VEGFR) expression with aneurysm development
in AAAs in an apolipoprotein E-deﬁcient (Apo E -/-)
murine AAA model. These murine models developed
suprarenal AAAs after infusion with angiotensin II (Ang
II mice). Selected mice were given either angiogenesis
inhibitors (Exel 0862) or doxycycline (positive control),
which is known to limit experimental AAA progression.36
Empty vehicle was given as a control to others and inacti-
vated VEGF probes (scVEGF/in) acted as a control for
nonreceptor-mediated reactions. NIRF imaging resulted
in signiﬁcantly higher VEGFR signal intensity for aneu-
rysmal aortic segments in relation to nonaneurysmal
segments in Ang II mice and control mice and Ang II
scVEGF/in mice. This association was conﬁrmed by
ﬂuorescence microscopy. Also, angiogenesis inhibition
seemed to signiﬁcantly limit AAA growth in controls vs
Exel 0862 and doxycycline. Mural inﬂammation too corre-
lated signiﬁcantly in Exel 0862- and doxycylin-treated mice
vs control vehicle-treated mice. The authors concluded
that VEGFR has deﬁnitive experimental value as a param-
eter for aneurysm progression. In the eventual case that
these results may translate to human pathology of AAAs,
this research may provide new diagnostic options in the
form of bio-optical imaging.35
DISCUSSION
There seem to be many contenders for validation of
AAA rupture risk. Unfortunately, most of the preliminaryand introductory studies that have been performed lack
scientiﬁc strength. Often, this was due to small or unbal-
anced cohort population size. Studies focused on clinical
implementation seem to be the heart of AAA research.
Their main goal is to enhance the diagnostic capabilities of
already existing imaging modalities. This clinically focused
research clusters known clinical entities, variables, and
comorbidities, and checks off against endpoints like aneu-
rysm growth and rupture. Except for smoking, familial
occurrence, vessel tortuosity, and diameter asymmetry,
most experimental variables were rejected as a risk factor
for AAA rupture. Calciﬁcation is a clinical entity that has
received little scientiﬁc attention (Fig 5). Just as thrombosis,
the effect of calciﬁcation on the integrity of the abdominal
aorta seems ambiguous. Calciﬁcation decreases elasticity
and compliance of a vessel. It can, therefore be hypothesized
that calciﬁcation adversely affects the vessel’s reactivity to
stress and as a consequence increases rupture risk.37
Abdominal aortic calciﬁcation has also been associated
with vascular morbidity and mortality.38 Contrary to these
statements, using US, Lindholt et al6 showed an increase
of calciﬁcation would reduce the need for intervention,
suggesting calciﬁcation has a protective role. Still, until
now, little else other than computational calciﬁcation
measurement studies have been focused on the meaning
of calciﬁcation. This lack of research on the subject is
theorized to be due to several limitations in CTA scans of
AAAs. The Agatston score is currently regarded as the
best validated method in coronary calciﬁcation measure-
ment. However, the Agatston score is inapplicable in
standard AAA CTA scanning. Since CTA uses contrast ﬂuid
to identify the abdominal aorta, a background signal is
produced that ﬂoods all intravascular high-density particles.
Noncontrast CT scans are of little value in routine vascular
imaging, and it is questionable whether performing both
a noncontrast and contrast CT is justiﬁable because this
will double the radiation exposure. The lack of method-
ology to investigate calciﬁcation in CTs needs to be over-
come for this speciﬁc ﬁeld of interest to be accurately
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Dual-energy CT uses two different tube voltages, which
could be set to both the absorption rates of calcium and
soft tissues like blood vessels. It, therefore, could bypass
the “contrast contamination.”This highly applicable update
to common CT imaging needs further investigation and
validation, but its potential should be recognized. Results
of these studies might be implemented inexpensively and
be highly feasible in medical practice.
Research in this ﬁeld is limited to the boundaries of exist-
ing modalities. Yet, experimental imaging modalities and
substrates can go where existing modalities fall short. For
example, the highly speciﬁc, radiation-independent imaging
of human biomarkers for AAA risk holds great promise. Bio-
optical imaging, however, is still limited to laboratory
studies, as both the modalities as the reagents are in many
ways unsuitable to be used in humans. Further development
that focuses on creating supporting materials will improve
practicality and might propel this ﬁeld to new heights.
Experimental use of MRI and PET-CT seems to be the
most promising new lead in AAA diagnostics. Their dual
function of both anatomic and functional imaging of the
abdominal aorta is a contribution and not an alternative to
the institutionalized US and CTA in AAA diagnostics. Of
value may be the next-generation PET-MRI camera for
simultaneous imaging of anatomy and function. The merits
of also being able to measure biochemical, inﬂammatory,
metabolic activity, apoptosis, and angiogenesis are highly
signiﬁcant. Fluctuation in inﬂammation and metabolism
may provide a better instant understanding of pharmaceu-
tical interactions with AAA or wall weakening on a much
shorter term. This is in stark contrast to US screening of
AAA growth, which is valuable only if repeated every 6
months. Nevertheless, a study by Osman et al39 showed
how clinically signiﬁcant ﬁndings such as cirrhosis, kidney
lesions, and AAAs on the CT portion of PET-CT were not
shown by PET or combined imaging. Although these ﬁnd-
ings are incidental, major diagnoses might be overlooked if
CTA interpretation moves to the background.
Fact remains that currently, aneurysm diameter is the
only criterion clinicians can rely on, even though this is
rapidly being considered to be less so. The amount of
unnecessary interventions for AAA repair and the degree
of risk taken when approaching a small aneurysm with
watchful waiting are equally unknown. We believe that
an expansion of the current paradigm surrounding the
AAA diameter toward a broader interpretation of biome-
chanical inﬂuences will be the next step in the prediction
of AAA rupture. Randomized clinical trials with any of
these methodologies or risk factors may still only be a future
prospect, but eventually their intellectual offspring might
provide a broad yet accurate screening protocol for the
risk assessment of the AAA.
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